GE HealthCare Technologies Inc. (GEHC) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
GE HealthCare Technologies Inc.
Address
500 West Monroe Street
Chicago, IL 60661
United States of America (the)
Phone
833 735 1139
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
54000
First IPO Date
December 15, 2022
Key Executives
| Name | Title | Pay | Year Born |
| Jeannette Bankes | President & Chief Executive Officer of Patient Care Solutions | 1.14M | 1971 |
| Peter J. Arduini | President, Chief Executive Officer & Director | 3.68M | 1965 |
| Kevin Michael O'Neill | President & Chief Executive Officer of Pharmaceutical Diagnostics | 0 | 1969 |
| Adam Holton | Chief People Officer | 1.78M | 1971 |
| James K. Saccaro | Vice President & Chief Financial Officer | 1.89M | 1973 |
| Taha Kass-Hout | Chief Science & Technology Officer | 1.9M | 1972 |
| Frank R. Jimenez | General Counsel & Corporate Secretary | 1.91M | 1965 |
| Kenneth R. Stacherski | Chief Global Supply Chain & Service Officer | 0 | 1972 |
| Rana Strellis | Chief Corporate Marketing & Communications Officer | 0 | N/A |
| Jahid Khandaker | Chief Information Officer | 0 | 1972 |
| George Andrew Newcomb | Controller & Chief Accounting Officer | 0 | 1967 |
| Carolynne Borders | Chief Investor Relations Officer | 0 | N/A |
Description
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
